| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | US20120010264 Novel medicament for treating cognitive impairment |
| 01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
| 01/12/2012 | US20120010262 Crystalline polymorphic forms of an antidiabetic compound |
| 01/12/2012 | US20120010261 Choline and tromethamine salt of licofelone |
| 01/12/2012 | US20120010260 Method for treating nervous system disorders and conditions |
| 01/12/2012 | US20120010259 Methods of Treating an Overweight or Obese Subject |
| 01/12/2012 | US20120010258 Additional therapeutic use |
| 01/12/2012 | US20120010257 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/12/2012 | US20120010256 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2012 | US20120010255 Compounds and Methods for Regulating Integrins |
| 01/12/2012 | US20120010254 Compounds and methods for treatment of influenza |
| 01/12/2012 | US20120010248 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof |
| 01/12/2012 | US20120010247 Bicyclic compound |
| 01/12/2012 | US20120010246 Compositions and methods for treating diseases of the nail |
| 01/12/2012 | US20120010245 Transdermal pharmaceutical compositions comprising a serm |
| 01/12/2012 | US20120010244 Indole derivatives as ikk2 inhibitors |
| 01/12/2012 | US20120010243 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects |
| 01/12/2012 | US20120010242 Low dose pipamperone in treating mood disorders |
| 01/12/2012 | US20120010241 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof |
| 01/12/2012 | US20120010240 CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| 01/12/2012 | US20120010239 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | US20120010238 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | US20120010237 Compounds having antiparasitic or anti-infectious activity |
| 01/12/2012 | US20120010236 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 01/12/2012 | US20120010235 N-substituted pyrrolidines |
| 01/12/2012 | US20120010234 Use of vegf-d in the diagnosis of lymphangioleiomyomatosis (lam) disease |
| 01/12/2012 | US20120010233 Methods and compositions to inhibit edema factor and adenylyl cyclase |
| 01/12/2012 | US20120010232 Compositions for affecting weight loss |
| 01/12/2012 | US20120010231 Dihydroetorphines and Their Preparation |
| 01/12/2012 | US20120010230 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/12/2012 | US20120010229 Therapeutic regimens for hedgehog-associated cancers |
| 01/12/2012 | US20120010228 D2 antagonists, methods of synthesis and methods of use |
| 01/12/2012 | US20120010227 Formulation for nail and nail bed diseases |
| 01/12/2012 | US20120010225 Pharmaceutical composition |
| 01/12/2012 | US20120010224 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines |
| 01/12/2012 | US20120010223 Isothiazolo-pyrimidinedione derivatives as trpai modulators |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010221 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 01/12/2012 | US20120010219 Salvinorin derivatives and uses thereof |
| 01/12/2012 | US20120010218 Formulations |
| 01/12/2012 | US20120010217 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/12/2012 | US20120010216 Pharmaceutical compositions containing vanoxerine |
| 01/12/2012 | US20120010215 Treatment of bacterial diseases of the respiratory organs |
| 01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
| 01/12/2012 | US20120010213 Oral controlled release dosage forms for water soluble drugs |
| 01/12/2012 | US20120010212 Methyl-pyrrolidine ether derivatives |
| 01/12/2012 | US20120010211 Pharmaceutical composition for treatment of type 2 diabetes |
| 01/12/2012 | US20120010210 L-Methylfolate Treatment for Psychiatric or Neurologic Disorders |
| 01/12/2012 | US20120010209 IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS |
| 01/12/2012 | US20120010208 6-CYCLOAMINO-3-(1H-PYRROLO[2,3-b]PYRIDIN-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 01/12/2012 | US20120010207 Chemical Compounds |
| 01/12/2012 | US20120010206 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/12/2012 | US20120010205 Novel quinoline esters useful for treating skin disorders |
| 01/12/2012 | US20120010204 Phthalazinone Derivatives |
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010201 Novel anellated pyridine compounds |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120010199 Novel pyrrolinone derivative and pharmaceutical composition comprising the same |
| 01/12/2012 | US20120010198 Methods for Treating Sleep Disorders by Cholecystokinin (CCK) Receptor B Antagonists |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010196 Methods of treating neurodegenerative disorders and diseases |
| 01/12/2012 | US20120010194 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
| 01/12/2012 | US20120010193 Cgrp receptor antagonists |
| 01/12/2012 | US20120010192 Fused Heterocyclic Compounds as Ion Channel Modulators |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010190 1-hydroxyimino-3-phenyl-propanes |
| 01/12/2012 | US20120010189 (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010187 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
| 01/12/2012 | US20120010186 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/12/2012 | US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
| 01/12/2012 | US20120010184 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor |
| 01/12/2012 | US20120010183 Chemical Compounds |
| 01/12/2012 | US20120010182 Chemical Compounds |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010180 Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 01/12/2012 | US20120010179 Methods of using a thiazole derivative |
| 01/12/2012 | US20120010178 Methods and compounds for treatment of neurodegenerative disorders |
| 01/12/2012 | US20120010177 MicroRNA Modulators and Method for Identifying And Using The Same |
| 01/12/2012 | US20120010176 Utrophin promoter activity upregulation for the treatment of muscular dystrophy |
| 01/12/2012 | US20120010175 Process for preparing malathion for pharmaceutical use |
| 01/12/2012 | US20120010174 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| 01/12/2012 | US20120010173 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations |
| 01/12/2012 | US20120010172 Novel urea and thiourea derivatives |
| 01/12/2012 | US20120010171 Nucleotide Analogue Prodrug and the Preparation Thereof |
| 01/12/2012 | US20120010170 "Methods of Reducing Nephrotoxicity in Subjects Administered Nucleoside Phosphonates" |
| 01/12/2012 | US20120010168 Unique Dual-Action Therapeutics |
| 01/12/2012 | US20120010167 Countermeasure methods and devices |
| 01/12/2012 | US20120010166 Stable iron oligosaccharide compound |
| 01/12/2012 | US20120010165 Potentiator of radiation therapy |
| 01/12/2012 | US20120010164 Antiviral agents |
| 01/12/2012 | US20120010163 Novel antibacterial compounds, methods of making them, and uses thereof |
| 01/12/2012 | US20120010162 Method for treatment of lung infections by administration of aminoglycosides by aerolisation |
| 01/12/2012 | US20120010161 Novel azapeptide or azapeptidomimetic compounds inhibiting bcrp and/or p-gp |
| 01/12/2012 | US20120010160 Rapidly Dissolving Oral Strip of Sugar for Hypoglycemia |
| 01/12/2012 | US20120010159 Combination therapies with cox-2 inhibitors and treprostinil |
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | US20120010127 Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same |